ERBB2 and breast cancer: Among the four classified subtypes of BC, luminal A and luminal B subtypes are ER and/or PR positive and the HER2 subtype is characterized by high HER2 expression and a lack of ER/PR, while triple-negative BC (TNBC) is characterized by the absence of ER/PR and HER2 overexpression [2].